(1)
ramirez, I.; Vera, Z.; Mastroianni, P.; Maciel, O.; Maidana, M.; Marin, L.; Marin, G.; Marin, G. H. Benefits of a National Program for Adverse Drugs Reactions (ADRS) Surveillance in Diabetic Patients. J. Drug Delivery Ther. 2022, 12 (4-S), 40-42. https://doi.org/10.22270/jddt.v12i4-S.5618.